University of Rochester Medical Center | Strategic Alliance Partners

This issue of Pharmacy Practice in Focus: Health Systems provides an overview of the considerations for the implementation of CRISPR and Cas9 cell-based gene therapies in sickle cell disease.

Moderator Curtis E. Haas, PharmD, FCCP; Deborah Simonson, PharmD; Andrew J. Donnelly, PharmD, MBA, FASHP; Noelle Chapman, PharmD, MBA, BCPS, FASHP; Todd Nesbit, PharmD, MBA, FASHP, discuss current challenges facing health-system pharmacies as well as potential solutions in areas such as staffing and financial stress.

Many patients have baseline risk factors present at diagnosis because of older age and disease-related elements.

Pharmacy Times® is pleased to announce that four new organizations have joined its Strategic Alliance Partnership program.

Pharmacy Times® interviewed Michael Flannery, PharmD, the assistant director of pharmacy operations at the University of Rochester Medical Center, on the process for managing the waiting period in the pharmacy following COVID-19 immunizations.

In this issue of Pharmacy Times® Health-System Edition, Grayson K. Peek, PharmD, and Halena Leah Marcelin, PharmD, offer a brief discussion of optimizing wholesale acquisition cost exposure for organizations participating in the federal 340B drug discount program when the group purchasing organization prohibition requirement applies.

We face many challenges in this very dynamic practice environment, with the prospects of declining revenue, increasing costs, major changes in reimbursement models, and ever-increasing demands on departments of pharmacy to positively affect drug-related outcomes and quality of care.